Pharma, fintech will see high investment activity in 2017: JSA’s Dina Wadia
Advertisement

Pharma, fintech will see high investment activity in 2017: JSA’s Dina Wadia

Dina Wadia has been practising law for three-and-a-half decades. She specialises in banking and finance, merger and acquisition deals as well as investment funds including private equity, venture capital and mutual fund vehicles. As the joint managing partner at J. Sagar Associates (JSA), she has been instrumental in propelling the ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News